These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17189268)

  • 21. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
    Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroviral integration site analysis identifies ICSBP as a collaborating tumor suppressor gene in NUP98-TOP1-induced leukemia.
    Gurevich RM; Rosten PM; Schwieger M; Stocking C; Humphries RK
    Exp Hematol; 2006 Sep; 34(9):1192-201. PubMed ID: 16939812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.
    Sourvinos G; Tavalai N; Berndt A; Spandidos DA; Stamminger T
    J Virol; 2007 Sep; 81(18):10123-36. PubMed ID: 17626080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35.
    Salsman J; Wang X; Frappier L
    Virology; 2011 Jun; 414(2):119-29. PubMed ID: 21489587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
    Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
    Chen Y; Wright J; Meng X; Leppard KN
    Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate immunity to intraphagosomal pathogens is mediated by interferon regulatory factor 8 (IRF-8) that stimulates the expression of macrophage-specific Nramp1 through antagonizing repression by c-Myc.
    Alter-Koltunoff M; Goren S; Nousbeck J; Feng CG; Sher A; Ozato K; Azriel A; Levi BZ
    J Biol Chem; 2008 Feb; 283(5):2724-33. PubMed ID: 18045875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EVI1 abrogates interferon-alpha response by selectively blocking PML induction.
    Buonamici S; Li D; Mikhail FM; Sassano A; Platanias LC; Colamonici O; Anastasi J; Nucifora G
    J Biol Chem; 2005 Jan; 280(1):428-36. PubMed ID: 15519999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2.
    Burchert A; Cai D; Hofbauer LC; Samuelsson MK; Slater EP; Duyster J; Ritter M; Hochhaus A; Müller R; Eilers M; Schmidt M; Neubauer A
    Blood; 2004 May; 103(9):3480-9. PubMed ID: 14656881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
    Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML).
    Grötzinger T; Sternsdorf T; Jensen K; Will H
    Eur J Biochem; 1996 Jun; 238(2):554-60. PubMed ID: 8681971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?
    Borden KL
    Biochim Biophys Acta; 2008 Nov; 1783(11):2145-54. PubMed ID: 18616965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
    Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
    J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions.
    Wang J; Shiels C; Sasieni P; Wu PJ; Islam SA; Freemont PS; Sheer D
    J Cell Biol; 2004 Feb; 164(4):515-26. PubMed ID: 14970191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PU.1 expression is restored upon treatment of chronic myeloid leukemia patients.
    Albajar M; Gutierrez P; Richard C; Rosa-Garrido M; Gómez-Casares MT; Steegmann JL; León J; Delgado MD
    Cancer Lett; 2008 Nov; 270(2):328-36. PubMed ID: 18635311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia.
    Tzoanopoulos D; Speletas M; Arvanitidis K; Veiopoulou C; Kyriaki S; Thyphronitis G; Sideras P; Kartalis G; Ritis K
    Br J Haematol; 2002 Oct; 119(1):46-53. PubMed ID: 12358902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors.
    Meraro D; Hashmueli S; Koren B; Azriel A; Oumard A; Kirchhoff S; Hauser H; Nagulapalli S; Atchison ML; Levi BZ
    J Immunol; 1999 Dec; 163(12):6468-78. PubMed ID: 10586038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis.
    Jo SH; Schatz JH; Acquaviva J; Singh H; Ren R
    Blood; 2010 Oct; 116(15):2759-67. PubMed ID: 20585039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.